Raymond D. Pratt
Dr. Pratt has served as Savara’s Chief Medical Officer since November 2022. He was most recently the Chief Medical and Chief Development Officer at Rockwell Medical Inc. Dr. Pratt is an accomplished senior executive and physician with more than 35 years of clinical medicine and drug development experience in global pharmaceutical and device industries. Previously, Dr. Pratt held senior roles at Eisai America, Shire Pharmaceuticals, and Quintiles Transnational. His expertise includes clinical research, regulatory affairs, clinical pharmacology and data analytics. Dr. Pratt has more than 40 peer reviewed publications and has contributed to multiple NDA, MAA and NDS applications in the fields of neurology, psychiatry, hematology, and nephrology. He received a M.D. from University of Illinois College of Medicine and a B.A. in Chemistry from Northwestern University.